Angel Yeast (600298): Performance exceeded expectations Expected improvement in second half Event description: The company achieved operating income in the first half of 201937. 14 ppm, an increase of 11 years. 6%, net profit 4. 64 ppm, a decrease of Read More
Xinmai Medical (688016): Leading enterprise of aorta and interventional vascular intervention Investment Overview The company is the leading enterprise of aorta and branch vascular intervention. The company is a minimally invasive medical subsidiary of a Hong Kong listed company. It Read More
Wuliangye (000858): Brand value gradually returns to approval The product structure continues to be optimized, and the brand value is expected to return strongly to the recent Wuliangye strategy to clean up some low-end products and the remaining products to Read More
Biyin Lefen (002832): Release of the Second Phase of Employee Stock Ownership Shows Confidence in Long-term Sustainable Development Investment Highlights: The company released the second phase of the employee stock ownership plan budget, and plans to raise no more than Read More
Enhua Pharmaceutical (002262): Steady growth of performance in line with expectations The event company released the 2019 first quarter report, reporting and realizing operating income10. 4.9 billion (+13. 31%), net profit attributable to mother 1. 2.6 billion (+23. 64%), deducting Read More
89 yuan performance in line with expectations Wanhua Chemical (600309) Quarterly Report Review 2019: EPS0 in the first quarter. 89 yuan performance in line with expectations Event: The company released the first quarter report and first quarter operating data for Read More
Wangneng Environment (002034) Annual Report 2018 Review: Replacement of Printing and Dyeing Light Loads, High Future Performance Growth Certainty Event: Wangneng Environment released the 2018 annual report, reporting and realizing operating income8. 3.6 billion, a decrease of 40 a year. Read More
Yiling Pharmaceutical (002603) In-depth Report: Steady Growth of Oral Preparations of Traditional Chinese Medicine, Chemicals and Health Business Entering Harvest Period Chinese patent medicine sector: evidence-based clinical academic basis and secondary development to escort the company’s series of fist products Read More
Gold Medal Kitchen Cabinet (603180) 2019 Semi-annual Report Comment: The overall performance of the rapid development of bulk business slightly exceeded expectations The company released its 2019 semi-annual report on August 21, 2019.In the first half of 2019, it realized Read More
ETF battle upgrades: public offerings shift from “price war” to “fine” layout ETF war upgrades competition: Public offerings have shifted from a “price war” to a “refined” layout Renwei, a notice from the Xia Xin Shenzhen Stock Exchange, adds another Read More